Hormonal contraceptive methods and risk of HIV acquisition in women: a systematic review of epidemiological evidence

Chelsea B. Polis, Sharon J. Phillips, Kathryn M. Curtis, Daniel J. Westreich, Petrus S. Steyn, Elizabeth Raymond, Philip Hannaford, Abigail Norris Turner

Research output: Contribution to journalArticle

62 Citations (Scopus)
4 Downloads (Pure)

Abstract

Whether use of various types of hormonal contraception (HC) affect risk of HIV acquisition is a critical question for women's health. For this systematic review, we identified 22 studies published by January 15, 2014 which met inclusion criteria; we classified thirteen studies as having severe methodological limitations, and nine studies as “informative but with important limitations”. Overall, data do not support an association between use of oral contraceptives and increased risk of HIV acquisition. Uncertainty persists regarding whether an association exists between depot-medroxyprogesterone acetate (DMPA) use and risk of HIV acquisition. Most studies suggested no significantly increased HIV risk with norethisterone enanthate (NET-EN) use, but when assessed in the same study, point estimates for NET-EN tended to be larger than for DMPA, though 95% confidence intervals overlapped substantially. No data have suggested significantly increased risk of HIV acquisition with use of implants, though data were limited. No data are available on the relationship between use of contraceptive patches, rings, or hormonal intrauterine devices and risk of HIV acquisition. Women choosing progestin-only injectable contraceptives such as DMPA or NET-EN should be informed of the current uncertainty regarding whether use of these methods increases risk of HIV acquisition, and like all women at risk of HIV, should be empowered to access and use condoms and other HIV preventative measures. Programs, practitioners, and women urgently need guidance on how to maximize health with respect to avoiding both unintended pregnancy and HIV given inconclusive or limited data for certain HC methods.
Original languageEnglish
Pages (from-to)360-390
Number of pages31
JournalContraception
Volume90
Issue number4
Early online date23 Jul 2014
DOIs
Publication statusPublished - Oct 2014

Fingerprint

Contraception
HIV
Medroxyprogesterone Acetate
Contraceptive Agents
Uncertainty
Intrauterine Devices
Condoms
Women's Health
Progestins
Oral Contraceptives
Confidence Intervals
Pregnancy
Injections
Health

Keywords

  • hormonal contraception
  • DMPA
  • injectable contraception
  • oral contraception
  • HIV acquisition
  • systematic review

Cite this

Polis, C. B., Phillips, S. J., Curtis, K. M., Westreich, D. J., Steyn, P. S., Raymond, E., ... Turner, A. N. (2014). Hormonal contraceptive methods and risk of HIV acquisition in women: a systematic review of epidemiological evidence. Contraception, 90(4), 360-390. https://doi.org/10.1016/j.contraception.2014.07.009

Hormonal contraceptive methods and risk of HIV acquisition in women : a systematic review of epidemiological evidence. / Polis, Chelsea B. ; Phillips, Sharon J. ; Curtis, Kathryn M.; Westreich, Daniel J.; Steyn, Petrus S.; Raymond, Elizabeth; Hannaford, Philip; Turner, Abigail Norris.

In: Contraception, Vol. 90, No. 4, 10.2014, p. 360-390.

Research output: Contribution to journalArticle

Polis, Chelsea B. ; Phillips, Sharon J. ; Curtis, Kathryn M. ; Westreich, Daniel J. ; Steyn, Petrus S. ; Raymond, Elizabeth ; Hannaford, Philip ; Turner, Abigail Norris. / Hormonal contraceptive methods and risk of HIV acquisition in women : a systematic review of epidemiological evidence. In: Contraception. 2014 ; Vol. 90, No. 4. pp. 360-390.
@article{3f255701bb174377bb561812a828cb6b,
title = "Hormonal contraceptive methods and risk of HIV acquisition in women: a systematic review of epidemiological evidence",
abstract = "Whether use of various types of hormonal contraception (HC) affect risk of HIV acquisition is a critical question for women's health. For this systematic review, we identified 22 studies published by January 15, 2014 which met inclusion criteria; we classified thirteen studies as having severe methodological limitations, and nine studies as “informative but with important limitations”. Overall, data do not support an association between use of oral contraceptives and increased risk of HIV acquisition. Uncertainty persists regarding whether an association exists between depot-medroxyprogesterone acetate (DMPA) use and risk of HIV acquisition. Most studies suggested no significantly increased HIV risk with norethisterone enanthate (NET-EN) use, but when assessed in the same study, point estimates for NET-EN tended to be larger than for DMPA, though 95{\%} confidence intervals overlapped substantially. No data have suggested significantly increased risk of HIV acquisition with use of implants, though data were limited. No data are available on the relationship between use of contraceptive patches, rings, or hormonal intrauterine devices and risk of HIV acquisition. Women choosing progestin-only injectable contraceptives such as DMPA or NET-EN should be informed of the current uncertainty regarding whether use of these methods increases risk of HIV acquisition, and like all women at risk of HIV, should be empowered to access and use condoms and other HIV preventative measures. Programs, practitioners, and women urgently need guidance on how to maximize health with respect to avoiding both unintended pregnancy and HIV given inconclusive or limited data for certain HC methods.",
keywords = "hormonal contraception , DMPA, injectable contraception, oral contraception, HIV acquisition, systematic review",
author = "Polis, {Chelsea B.} and Phillips, {Sharon J.} and Curtis, {Kathryn M.} and Westreich, {Daniel J.} and Steyn, {Petrus S.} and Elizabeth Raymond and Philip Hannaford and Turner, {Abigail Norris}",
year = "2014",
month = "10",
doi = "10.1016/j.contraception.2014.07.009",
language = "English",
volume = "90",
pages = "360--390",
journal = "Contraception",
issn = "0010-7824",
publisher = "Elsevier USA",
number = "4",

}

TY - JOUR

T1 - Hormonal contraceptive methods and risk of HIV acquisition in women

T2 - a systematic review of epidemiological evidence

AU - Polis, Chelsea B.

AU - Phillips, Sharon J.

AU - Curtis, Kathryn M.

AU - Westreich, Daniel J.

AU - Steyn, Petrus S.

AU - Raymond, Elizabeth

AU - Hannaford, Philip

AU - Turner, Abigail Norris

PY - 2014/10

Y1 - 2014/10

N2 - Whether use of various types of hormonal contraception (HC) affect risk of HIV acquisition is a critical question for women's health. For this systematic review, we identified 22 studies published by January 15, 2014 which met inclusion criteria; we classified thirteen studies as having severe methodological limitations, and nine studies as “informative but with important limitations”. Overall, data do not support an association between use of oral contraceptives and increased risk of HIV acquisition. Uncertainty persists regarding whether an association exists between depot-medroxyprogesterone acetate (DMPA) use and risk of HIV acquisition. Most studies suggested no significantly increased HIV risk with norethisterone enanthate (NET-EN) use, but when assessed in the same study, point estimates for NET-EN tended to be larger than for DMPA, though 95% confidence intervals overlapped substantially. No data have suggested significantly increased risk of HIV acquisition with use of implants, though data were limited. No data are available on the relationship between use of contraceptive patches, rings, or hormonal intrauterine devices and risk of HIV acquisition. Women choosing progestin-only injectable contraceptives such as DMPA or NET-EN should be informed of the current uncertainty regarding whether use of these methods increases risk of HIV acquisition, and like all women at risk of HIV, should be empowered to access and use condoms and other HIV preventative measures. Programs, practitioners, and women urgently need guidance on how to maximize health with respect to avoiding both unintended pregnancy and HIV given inconclusive or limited data for certain HC methods.

AB - Whether use of various types of hormonal contraception (HC) affect risk of HIV acquisition is a critical question for women's health. For this systematic review, we identified 22 studies published by January 15, 2014 which met inclusion criteria; we classified thirteen studies as having severe methodological limitations, and nine studies as “informative but with important limitations”. Overall, data do not support an association between use of oral contraceptives and increased risk of HIV acquisition. Uncertainty persists regarding whether an association exists between depot-medroxyprogesterone acetate (DMPA) use and risk of HIV acquisition. Most studies suggested no significantly increased HIV risk with norethisterone enanthate (NET-EN) use, but when assessed in the same study, point estimates for NET-EN tended to be larger than for DMPA, though 95% confidence intervals overlapped substantially. No data have suggested significantly increased risk of HIV acquisition with use of implants, though data were limited. No data are available on the relationship between use of contraceptive patches, rings, or hormonal intrauterine devices and risk of HIV acquisition. Women choosing progestin-only injectable contraceptives such as DMPA or NET-EN should be informed of the current uncertainty regarding whether use of these methods increases risk of HIV acquisition, and like all women at risk of HIV, should be empowered to access and use condoms and other HIV preventative measures. Programs, practitioners, and women urgently need guidance on how to maximize health with respect to avoiding both unintended pregnancy and HIV given inconclusive or limited data for certain HC methods.

KW - hormonal contraception

KW - DMPA

KW - injectable contraception

KW - oral contraception

KW - HIV acquisition

KW - systematic review

U2 - 10.1016/j.contraception.2014.07.009

DO - 10.1016/j.contraception.2014.07.009

M3 - Article

VL - 90

SP - 360

EP - 390

JO - Contraception

JF - Contraception

SN - 0010-7824

IS - 4

ER -